Literature DB >> 12674095

Voxeldoes: a computer program for 3-D dose calculation in therapeutic nuclear medicine.

Isabelle Gardin1, Lionel G Bouchet, Karine Assié, Jerome Caron, Albert Lisbona, Ludovic Ferrer, Wesley E Bolch, Pierre Vera.   

Abstract

A computer program, VoxelDose, was developed to calculate patient specific 3-D-dose maps at the voxel level. The 3-D dose map is derived in three steps: (i) The SPECT acquisitions are reconstructed using a filtered back projection method, with correction for attenuation and scatter; (ii) the 3-D cumulated activity map is generated by integrating the SPECT data; and (iii) a 3-D dose map is computed by convolution (using the Fourier Transform) of the cumulated activity map and corresponding MIRD voxel S values. To validate the VoxelDose software, a Liqui-Phil abdominal phantom with four simulated organ inserts and one spherical tumor (radius 4.2 cm) was filled with known activity concentrations of 111In. Four cylindrical calibration tubes (from 3.7 to 102 kBq/mL) were placed on the phantom. Thermoluminescent mini-dosimeters (mini-TLDs) were positioned on the surface of the organ inserts. Percent differences between the known and measured activity concentrations were determined to be 12.1 (tumor), 1.8 (spleen), 1.4, 8.1 (right and left kidneys), and 38.2% (liver), leading to percent differences between the calculated and TLD measured doses of 41, 16, 3, 5, and 62%. Large differences between the measured and calculated dose in the tumor and the liver may be attributed to several reasons, such as the difficulty in precisely associating the position of the TLD to a voxel and limits of the quantification method (mainly the scatter correction and partial volume effect). Further investigations should be performed to better understand the impact of each effect on the results and to improve absolute quantification. For all other organs, activity concentration measurements and dose calculations agree well with the known activity concentrations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12674095     DOI: 10.1089/108497803321269386

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  11 in total

1.  Method for Fast CT/SPECT-Based 3D Monte Carlo Absorbed Dose Computations in Internal Emitter Therapy.

Authors:  S J Wilderman; Y K Dewaraja
Journal:  IEEE Trans Nucl Sci       Date:  2007-02-17       Impact factor: 1.679

2.  Activity estimation in radioimmunotherapy using magnetic nanoparticles.

Authors:  Samira Rasaneh; Hossein Rajabi; Fariba Johari Daha
Journal:  Chin J Cancer Res       Date:  2015-04       Impact factor: 5.087

3.  Study of the impact of tissue density heterogeneities on 3-dimensional abdominal dosimetry: comparison between dose kernel convolution and direct Monte Carlo methods.

Authors:  Arnaud Dieudonné; Robert F Hobbs; Rachida Lebtahi; Fabien Maurel; Sébastien Baechler; Richard L Wahl; Ariane Boubaker; Dominique Le Guludec; Georges Sgouros; Isabelle Gardin
Journal:  J Nucl Med       Date:  2012-12-18       Impact factor: 10.057

4.  A review of 3D image-based dosimetry, technical considerations and emerging perspectives in 90Y microsphere therapy.

Authors:  Jim O' Doherty
Journal:  J Diagn Imaging Ther       Date:  2015-04-28

5.  Development and Validation of RAPID: A Patient-Specific Monte Carlo Three-Dimensional Internal Dosimetry Platform.

Authors:  Abigail E Besemer; You Ming Yang; Joseph J Grudzinski; Lance T Hall; Bryan P Bednarz
Journal:  Cancer Biother Radiopharm       Date:  2018-04-25       Impact factor: 3.099

Review 6.  Preclinical Voxel-Based Dosimetry in Theranostics: a Review.

Authors:  Arun Gupta; Min Sun Lee; Joong Hyun Kim; Dong Soo Lee; Jae Sung Lee
Journal:  Nucl Med Mol Imaging       Date:  2020-04-19

7.  Clinical implementation of PLANET® Dose for dosimetric assessment after [177Lu]Lu-DOTA-TATE: comparison with Dosimetry Toolkit® and OLINDA/EXM® V1.0.

Authors:  Lore Santoro; L Pitalot; D Trauchessec; E Mora-Ramirez; P O Kotzki; M Bardiès; E Deshayes
Journal:  EJNMMI Res       Date:  2021-01-04       Impact factor: 3.138

8.  Comparison of commercial dosimetric software platforms in patients treated with 177 Lu-DOTATATE for peptide receptor radionuclide therapy.

Authors:  Erick Mora-Ramirez; Lore Santoro; Emmanuelle Cassol; Juan C Ocampo-Ramos; Naomi Clayton; Gunjan Kayal; Soufiane Chouaf; Dorian Trauchessec; Jean-Pierre Pouget; Pierre-Olivier Kotzki; Emmanuel Deshayes; Manuel Bardiès
Journal:  Med Phys       Date:  2020-07-31       Impact factor: 4.071

Review 9.  Current Status of Radiopharmaceutical Therapy.

Authors:  Sara St James; Bryan Bednarz; Stanley Benedict; Jeffrey C Buchsbaum; Yuni Dewaraja; Eric Frey; Robert Hobbs; Joseph Grudzinski; Emilie Roncali; George Sgouros; Jacek Capala; Ying Xiao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-08-14       Impact factor: 7.038

10.  Yttrium-90 quantitative phantom study using digital photon counting PET.

Authors:  Joey Labour; Philippe Boissard; David Sarrut; Jean-Noël Badel; Thomas Baudier; Fouzi Khayi; David Kryza; Pascale Veyrat Durebex; Sandrine Parisse-Di Martino; Thomas Mognetti
Journal:  EJNMMI Phys       Date:  2021-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.